1. Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)

   • Michael Sandherr
   • Marcus Hentrich
   • Oliver A. Cornely

   Original Article Open access 21 July 2015 Pages: 1441 - 1450

   

2. Prediction of central venous catheter–related bloodstream infections (CRBSIs) in patients with haematologic malignancies using a modified Infection Probability Score (mIPS)

   • Enrico Schalk
   • Lynn Hanus
   • Florian H. Heidel

   Original Article 03 May 2015 Pages: 1451 - 1456

3. Desmopressin improves platelet function in uremic patients taking antiplatelet agents who require emergent invasive procedures

   • Ji Hyun Kim
   • Chung Hee Baek
   • Hyosang Kim

   Original Article 03 May 2015 Pages: 1457 - 1461

4. Anti-coagulation assessment with prothrombin time and anti-Xa assays in real-world patients on treatment with rivaroxaban

   • Oliver Königsbrügge
   • Peter Quehenberger
   • Cihan Ay

   Original Article 30 May 2015 Pages: 1463 - 1471

   

5. Headache prevalence following recovery from TTP and aHUS

   • Jennifer N. Saultz
   • Haifeng M. Wu
   • Spero Cataland

   Original Article 11 June 2015 Pages: 1473 - 1476

6. HES1 activation suppresses proliferation of leukemia cells in acute myeloid leukemia

   • Chen Tian
   • Yong Yu
   • Yizhuo Zhang

   Original Article 21 June 2015 Pages: 1477 - 1483

   

7. Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines

   • Dae Sik Kim
   • Ka-Won Kang
   • Byung Soo Kim

   Original Article 06 May 2015 Pages: 1485 - 1492

   

8. Aberrant germinal center formation, follicular T-helper cells, and germinal center B-cells were involved in chronic graft-versus-host disease

   • Liang Shao
   • Albert K. W. Lie
   • Yok-Lam Kwong

   Original Article 12 May 2015 Pages: 1493 - 1504

   

9. Plasma microRNA-586 is a new biomarker for acute graft-versus-host disease

   • Yinuo Wang
   • Xiaosu Zhao
   • Jun Wan

   Original Article 09 June 2015 Pages: 1505 - 1514

   

10. The extent of local tumor invasion predicts prognosis in stage I_E nasal natural killer/T-cell lymphoma: a novel T staging system for risk stratification

    • Xi-wen Bi
    • Wen-wen Zhang
    • Wen-qi Jiang

    Original Article 01 May 2015 Pages: 1515 - 1524

    

11. Radiotherapy and PGEMOX/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK/T-cell lymphoma

    • Xi-wen Bi
    • Yi Xia
    • Zhi-ming Li

    Original Article 10 May 2015 Pages: 1525 - 1533

    

12. High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type

    • Hua Wang
    • Pengfei Li
    • ZhiMing Li

    Original Article 21 May 2015 Pages: 1535 - 1544

    

13. Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma

    • Semra Paydas
    • Emine Bağır
    • Melek Ergin

    Original Article 26 May 2015 Pages: 1545 - 1552

    

14. Bendamustine as first-line treatment in patients with advanced indolent non-Hodgkin lymphoma and mantle cell lymphoma in German routine clinical practice

    • M. Becker
    • B. Tschechne
    • L. Straßl

    Original Article Open access 28 June 2015 Pages: 1553 - 1558

    

15. Hospital population screening reveals overrepresentation of CD5⁻ monoclonal B-cell lymphocytosis and monoclonal gammopathy of undetermined significance of IgM type

    • Minna Voigtlaender
    • Birthe Vogler
    • Mascha Binder

    Original Article 05 June 2015 Pages: 1559 - 1565

    

16. Is there any complimentary role of F-18 NaF PET/CT in detecting of osseous involvement of multiple myeloma? A comparative study for F-18 FDG PET/CT and F-18 FDG NaF PET/CT

    • İlknur Ak
    • Hasan Onner
    • Olga Meltem Akay

    Original Article 13 June 2015 Pages: 1567 - 1575

    

17. Trained clinical nurse specialists proficiently obtain bone marrow aspirates and trephine biopsies in a nearly painless procedure—a prospective evaluation study

    • M. Naegele
    • L. Leppla
    • M. Engelhardt

    Original Article 02 June 2015 Pages: 1577 - 1584

    

18. Ruxolitinib- but not fedratinib-induced extreme thrombocytosis: the combination therapy with hydroxyurea and ruxolitinib is effective in reducing platelet count and splenomegaly/constitutional symptoms

    • N. Polverelli
    • L. Catani
    • F. Palandri

    Letter to the Editor 16 May 2015 Pages: 1585 - 1587

    

19. Severe sustained hypoplastic bone marrow after immunosuppressive therapy in malignant lymphoma cases with anti-centromere protein-B antibody

    • Rie Tabata
    • Chiharu Tabata
    • Masaru Kojima

    Letter to the Editor 13 May 2015 Pages: 1589 - 1591

    

20. Synchronous Hodgkin’s lymphoma and schwannomas mimicking refractory Hodgkin’s lymphoma

    • Onno C. Leeksma
    • Rick L. M. Haas
    • Aart Brutel de la Rivière

    Letter to the Editor 31 May 2015 Pages: 1593 - 1595

    

21. Atypical presentations of thrombotic thrombocytopenic purpura in middle-aged women with recurrent cerebral macrovascular thrombosis: a case report

    • Alessandro Lucchesi
    • Pier Paolo Fattori
    • Mariasanta Napolitano

    Letter to the Editor 09 June 2015 Pages: 1597 - 1598

22. A novel MYH9 mutation in a patient with MYH9 disorders and platelet size-specific effect of romiplostim on macrothrombocytopenia

    • Jun Yamanouchi
    • Takaaki Hato
    • Masaki Yasukawa

    Letter to the Editor 09 June 2015 Pages: 1599 - 1600

    

23. Effect of combined deferasirox and 5-azacytidine treatment on human leukemia cells in vitro

    • Satoshi Imanishi
    • Ryoko Takahashi
    • Junko H. Ohyashiki

    Letter to the Editor 06 June 2015 Pages: 1601 - 1602

    

24. Localized LECT2 amyloidosis of the adrenal gland with coexisting MGUS: a diagnostic challenge

    • Trevor E. Angell
    • Abhisek Swaika
    • Sikander Ailawadhi

    Letter to the Editor 07 June 2015 Pages: 1603 - 1604

    

25. Thrombotic thrombocytopenic purpura in a patient with lenalidomide-responsive multiple myeloma

    • Chan Yoon Cheah
    • Robert Z. Orlowski
    • Thein H. Oo

    Letter to the Editor 05 June 2015 Pages: 1605 - 1607

    

26. Negative PET: no guarantee of good prognosis in Hodgkin’s lymphoma

    • Hugo J. A. Adams
    • Thomas C. Kwee

    Letter to the Editor 14 June 2015 Pages: 1609 - 1610

27. Evidence-based reflection on the value of FDG-PET for interim and end-of-treatment response assessment in diffuse large B-cell lymphoma

    • Hugo J. A. Adams
    • Thomas C. Kwee

    Letter to the Editor 12 June 2015 Pages: 1611 - 1613

    

28. Analysis of survival by tumor response: have we learnt any better?

    • Gabriele Ihorst
    • Johannes Waldschmidt
    • Monika Engelhardt

    Letter to the Editor 24 June 2015 Pages: 1615 - 1616

29. Loss of response to azacitidine is associated with deletion 12p13 in a patient with myelodysplastic syndrome with unique translocation t(13;17)(q12;q25) after prior breast cancer and acute promyelocytic leukemia

    • Marko Lucijanic
    • Ruzica Lasan-Trcic
    • Ozren Jaksic

    Letter to the Editor 20 June 2015 Pages: 1617 - 1619